Actively Recruiting

Phase Not Applicable
Age: 55Years - 69Years
MALE
Healthy Volunteers
NCT05926102

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

Led by VA Office of Research and Development · Updated on 2026-01-13

5000

Participants Needed

1

Research Sites

347 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death. Current methods of screening men for prostate cancer are inaccurate and cannot identify which men do not have prostate cancer or have low-grade cases that will not cause harm and which men have significant prostate cancer needing treatment. False-positive screening tests can result in unnecessary prostate biopsies for men who do not need them. However, new genetic testing might help identify which men are at highest risk for prostate cancer. This study will examine whether a genetic test helps identify men at risk for significant prostate cancer while helping men who are at low risk for prostate cancer avoid unnecessary biopsies. If this genetic test proves beneficial, it will improve the way that healthcare providers screen male Veterans for prostate cancer.

CONDITIONS

Official Title

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

Who Can Participate

Age: 55Years - 69Years
MALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 55 and 69 years
  • Receiving regular care at the VA
  • Veteran status
Not Eligible

You will not qualify if you...

  • Personal history of prostate cancer
  • Prior prostate biopsy, prostatectomy, or prostate MRI
  • Known carrier of a rare genetic variant linked to cancer syndrome

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Boston, Massachusetts, United States, 02130-4817

Actively Recruiting

Loading map...

Research Team

C

Charles A Brunette, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here